-J Waltenberger Researcher Activity Profile

Research Author Detailed Information 

J Waltenberger Publication Rate By Year

J Waltenberger has published 1 paper(s) in 2002, 1 paper(s) in 2005, 8 paper(s) in 2007, 7 paper(s) in 2008, for a total of 17 research publications in total.

J J Waltenberger Author Information

LAST NAME: waltenberger

FIRST NAME: J

INITIALS: j

AFFILIATION:

Papers

J Waltenberger's Publication Record

1. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Year Published: 2002
Orthopaedic Department (RKU), University of Ulm, Ulm, Germany.
2. -455G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement. Year Published: 2005
Department of Cardiology, Leiden University Medical Center, The Netherlands. J.W.Jukema@lumc.nl
3. A novel breast cancer cell line initially established from pleural effusion: evolution towards a more aggressive phenotype. Year Published: 2007
Department of Cancer Biology, University of Massachusetts Medical School, LRB-470X, 364 Plantation Street, Worcester, MA 01605, USA. melanie_weigand@hotmail.de
4. Letter to the editors. Year Published: 2007
Department of Cardiology, University Hospital of Maastricht and Cardiovascular Research Institute of Maastricht (CARIM), University of Maastricht, P. Debyelaan 25, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands, j.waltenberger@cardio.azm.nl.
5. Stress testing at the cellular and molecular level to unravel cellular dysfunction and growth factor signal transduction defects: what Molecular Cell Biology can learn from Cardiology. Year Published: 2007
Department of Cardiology, University of Maastricht, Maastricht, The Netherlands. j.waltenberger@cardio.azm.nl
6. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions. Year Published: 2007
Leiden University Medical Center, Department of Cardiology, C5-P, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: J.W.Jukema@lumc.nl.
7. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. Year Published: 2007
8. Stress testing at the cellular and molecular level to unravel cellular dysfunction and growth factor signal transduction defects: what Molecular Cell Biology can learn from Cardiology. Year Published: 2007
Department of Cardiology, University of Maastricht, Maastricht, The Netherlands. j.waltenberger@cardio.azm.nl
9. Monocyte function rather than number is a prerequisite for the stimulation of collateral growth. Year Published: 2008
Department of Cardiology, University of Maastricht, Maastricht, The Netherlands.
10. Monocyte function rather than number is a prerequisite for the stimulation of collateral growth. Year Published: 2008
11. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions. Year Published: 2007
Leiden University Medical Center, Department of Cardiology, C5-P, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
12. Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction. Year Published: 2008
Department of Cardiology, University Hospital of Maastricht, P. Debyelaan 25, PO Box 5800, 6202AZ Maastricht, The Netherlands.
13. The Molecular Basis of VEGFR-1 Signal Transduction Pathways in Primary Human Monocytes. Year Published: 2008
Department of Cardiology, University Hospital of Maastricht, Cardiovascular Research Institute of Maastricht, P.Debyelaan 25, P.O. Box 5800, 6202 AZ Maastricht, the Netherlands. j.waltenberger@cardio.azm.nl.
14. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Year Published: 2008
Department of Cardiology, University Hospital of Maastricht, Cardiovascular Research Institute of Maastricht, P.Debyelaan 25, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
15. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. Year Published: 2007
16. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Year Published: 2008
Department of Cardiology, University Hospital of Maastricht, Cardiovascular Research Institute of Maastricht, P.Debyelaan 25, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
17. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial. Year Published: 2008
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands.